Talecris Biotherapeutics, Inc.

Talecris Biotherapeutics, Inc. is a leading biopharmaceutical company focused on developing, producing, and marketing plasma-derived protein therapies. The company's commitment is to extend and enhance the lives of individuals suffering from chronic and acute, often life-threatening, conditions. Talecris Biotherapeutics, Inc. is dedicated to providing innovative therapeutic solutions to address critical healthcare needs.

With a broad portfolio of products, Talecris Biotherapeutics, Inc. addresses conditions such as chronic inflammatory demyelinating polyneuropathy (CIDP), primary immune deficiencies (PI), alpha-1 antitrypsin deficiency, bleeding disorders, infectious diseases, and severe trauma. These therapies are derived from human plasma, sourced from plasma collection centers and trusted third-party providers located in the United States, ensuring the highest quality and safety standards. The primary address of Talecris Biotherapeutics, Inc. is 79 T. W. Alexander Drive, 4101 Research Commons, Research Triangle Park, NC 27709, US.

Talecris Biotherapeutics, Inc. is committed to advancing the field of biotherapeutics through continuous research, development, and innovation. The company aims to improve patient outcomes and contribute to the well-being of communities worldwide. Talecris Biotherapeutics, Inc. invites you to discover more about their life-saving therapies and dedication to healthcare. Company management will soon complete more information about Talecris Biotherapeutics.

To the manager of Talecris Biotherapeutics, we invite you to create a customized and exclusive company showcase and product listing on our platform to further enhance your company's visibility and market reach.